ACLEXA

Brand name authorized in: Lithuania Poland

Active ingredients

The drug ACLEXA contains one active pharmaceutical ingredient (API):

1 Celecoxib
UNII JCX84Q7J1L - CELECOXIB

Celecoxib is an oral, selective, cyclooxygenase-2 (COX-2) inhibitor within the clinical dose range (200-400 mg daily). No statistically significant inhibition of COX-1 (assessed as ex vivo inhibition of thromboxane B2 [TxB2] formation) was observed in this dose range in healthy volunteers.

Read about Celecoxib

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Celecoxib
M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AH Coxibs
Discover more medicines within M01AH01

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
LT
Valstybinė vaistų kontrolės tarnyba
Identifier(s): 1068247, 1068248, 1072200, 1072201, 1072202, 1072203, 1072204, 1072205, 1072206, 1072207, 1072208, 1072209, 1072210, 1072211, 1072212, 1072213